Navigation Links
The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research

ALBANY, New York, May 21, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued at USD 2.4 billion in 2011 and is expected to grow at a CAGR of 10.1% from 2012 to 2018, to reach an estimated value of USD 4.7 billion in 2018.

Browse the full report at

The most important growth driver of this market is the increasing application of genomics and proteomics in cancer treatment research, leading to an increase in the use of microarrays and reagents. Furthermore, growth in drug discovery, personalized medicine and life science research, along with developments such as the U.S. FDA approval of personalized medicines for treatment of melanoma and lung cancer will also support future growth of this market.

Microarrays held the majority share of the total market in 2011, on account of technological advancements in the field of microarrays and increased commercial application of biochips post the success of the Human Genome Project (HGP). Within this segment, the highest market share is held by DNA chips, due to increasing gene expression profiling in drug delivery and epidemiological research. The laboratory and protein chip segments are expected to experience maximum growth within the microarrays segment, due to product advancements and broadening capabilities in drug delivery and diagnostic testing. The market for reagents and other consumables holds the potential for highest growth; it is expected to grow at a CAGR of 10.7% from 2012 to 2018, due to the need for higher quality of sample preparation, and labeling and purification agents.

Related & Recently Published Reports by Transparency Market Research

Drug delivery held the highest market share by application in 2011, at over 50%, on account of the increased use of biochip technology in gene expression analysis, single nucleotide polymorphism (SNP) identification and genotyping, protein analysis and characterization in drug delivery. The market for other applications including disease management, forensic medicine, military and defense applications, and agriculture, will witness the highest growth rate during the forecast period.

Related & Recently Published Reports by Transparency Market Research

The key market players in the U.S. biochip market are Affymetrix, Inc., Life Technologies Corporation and Illumina, Inc. Other important market players include Becton, Dickinson and Company and Agilent Technologies. The market witnesses low product differentiation, and increasing strategic alliances and collaborative developments.

The U.S. biochip market is categorized into the following segments:

  • Biochip Market, by Segments
    • Biochip Products Market
    • Biochip Services Market
  • Biochip Products Market, by Types
    • Microarrays
    • Reagents and Other Consumables
    • Others (Biochip Instruments and Software)
  • Biochip Products and Services Market, by Applications
    • Drug Delivery
    • Life Science Research
    • In Vitro Diagnostic Testing
    • Others (Disease Management, Forensic Medicine, Defense)

Browse all Medical Devices Market Research Reports@

Upcoming Reports in Medical Devices Market

Healthcare Microchip Array Market

Oncology Devices Market

Radiation Detection, Monitoring and Safety Market

PreClinical Imaging Market

Digital Radiology Market

Diagnostic Electrocardiograph (DECG) Market

Medical Plastics Market

Nanomedical Devices and Therapeutics Market

Medical Bionic Implant Market

Endoscopy Devices Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Biochips and Microarrays 2013 Market Report
2. New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests
3. Revolutionary Science Announces New Automatic and Manual Colony Counting Products
4. Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive
5. New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products
6. Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products
7. New Temperature Control Products Announced by Oven Industries Inc.
8. Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
9. Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount
10. Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help
11. Bed Bug Treatment Cost Leaves Tenant No Choice But to Move, My Cleaning Products Offers Aid How to Get Rid of Bed Bugs Without Spending Big
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):